Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
Invesco Solar ETF
TAN
United States Natural Gas
UNG
4
VanEck Semiconductor ETF
SMH
5
The Technology Select Sector SPDR® Fund
XLK
US Stock MarketDetailed Quotes
Akebia Therapeutics (AKBA)
- 0.9703
- +0.0006+0.06%
Close Jun 4 16:00 ET
- 0.9701
- -0.0002-0.02%
Post 17:40 ET
260.29MMarket Cap-12.13P/E (TTM)
0.9999High0.9601Low2.39MVolume0.9683Open0.9697Prev Close2.33MTurnover0.91%Turnover RatioLossP/E (Static)268.26MShares4.078752wk High9.51P/B254.50MFloat Cap0.875052wk Low--Dividend TTM262.29MShs Float31.0000Historical High--Div Yield TTM4.10%Range %0.2410Historical Low0.9769Avg Price1Lot Size
AKBA Stock Chart
After-Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
AKBA Orderflow
Unit: --
AKBA Orderflow Trend
IntradayDayWeekMonth
No Data
Akebia Therapeutics (AKBA) News
Express News | Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
Akebia Therapeutics Earnings Call: Vafseo Drives Transition
Akebia Therapeutics Balances Vafseo Momentum With Headwinds
Akebia Therapeutics, Inc. (NASDAQ:AKBA): Is Breakeven Near?
Akebia Therapeutics (AKBA) Stock Forum
$Akebia Therapeutics (AKBA.US)$ drop to belo w 1
$Akebia Therapeutics (AKBA.US)$
Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology
by Globe Newswire
Follow
CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today...
Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology
by Globe Newswire
Follow
CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today...
1
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)